1-1 of 1
for the French Acute Myeloid Leukemia (AML) Intergroup including the Groupe Ouest-Est des Leucémies Aiguës Myéloblastiques (GOELAM), the Leucémies Aiguës Myéloblastiques de l'Enfant (LAME), the Acute Leukemia French Association (ALFA), and the Bordeaux-Grenoble-Marseille-Toulouse (BGMT) cooperative groups
Close
Sort by
Journal Articles

Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup

Clinical Trials & Observations
Jacques Delaunay, Norbert Vey, Thierry Leblanc, Pierre Fenaux, Françoise Rigal-Huguet, Francis Witz, Thierry Lamy, Anne Auvrignon, Didier Blaise, Arnaud Pigneux, Francine Mugneret, Christian Bastard, Nicole Dastugue, Jacqueline Van den Akker, Denis Fière, Josy Reiffers, Sylvie Castaigne, Guy Leverger, Jean-Luc Harousseau, Hervé Dombret, for the French Acute Myeloid Leukemia (AML) Intergroup including the Groupe Ouest-Est des Leucémies Aiguës Myéloblastiques (GOELAM), the Leucémies Aiguës Myéloblastiques de l'Enfant (LAME), the Acute Leukemia French Association (ALFA), and the Bordeaux-Grenoble-Marseille-Toulouse (BGMT) cooperative groups
Journal: Blood
Blood (2003) 102 (2): 462–469.
https://doi.org/10.1182/blood-2002-11-3527
Published: 2003